PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MS vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MS and JNJ is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

MS vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Morgan Stanley (MS) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
18.71%
-2.83%
MS
JNJ

Key characteristics

Sharpe Ratio

MS:

1.54

JNJ:

-0.51

Sortino Ratio

MS:

2.21

JNJ:

-0.66

Omega Ratio

MS:

1.31

JNJ:

0.92

Calmar Ratio

MS:

2.30

JNJ:

-0.45

Martin Ratio

MS:

9.14

JNJ:

-1.18

Ulcer Index

MS:

4.43%

JNJ:

6.71%

Daily Std Dev

MS:

26.41%

JNJ:

15.44%

Max Drawdown

MS:

-88.12%

JNJ:

-52.60%

Current Drawdown

MS:

-8.15%

JNJ:

-15.81%

Fundamentals

Market Cap

MS:

$205.99B

JNJ:

$342.53B

EPS

MS:

$6.59

JNJ:

$6.05

PE Ratio

MS:

19.40

JNJ:

23.52

PEG Ratio

MS:

3.63

JNJ:

0.85

Total Revenue (TTM)

MS:

$43.27B

JNJ:

$66.30B

Gross Profit (TTM)

MS:

$19.98B

JNJ:

$45.96B

EBITDA (TTM)

MS:

$15.42B

JNJ:

$22.61B

Returns By Period

In the year-to-date period, MS achieves a -1.38% return, which is significantly lower than JNJ's -0.10% return. Over the past 10 years, MS has outperformed JNJ with an annualized return of 16.70%, while JNJ has yielded a comparatively lower 6.25% annualized return.


MS

YTD

-1.38%

1M

-2.68%

6M

19.79%

1Y

43.26%

5Y*

22.55%

10Y*

16.70%

JNJ

YTD

-0.10%

1M

-1.47%

6M

-1.68%

1Y

-8.22%

5Y*

2.47%

10Y*

6.25%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MS vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MS
The Risk-Adjusted Performance Rank of MS is 8989
Overall Rank
The Sharpe Ratio Rank of MS is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of MS is 8585
Sortino Ratio Rank
The Omega Ratio Rank of MS is 8686
Omega Ratio Rank
The Calmar Ratio Rank of MS is 9393
Calmar Ratio Rank
The Martin Ratio Rank of MS is 9191
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2020
Overall Rank
The Sharpe Ratio Rank of JNJ is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 1919
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2020
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2222
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MS vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley (MS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MS, currently valued at 1.54, compared to the broader market-2.000.002.001.54-0.51
The chart of Sortino ratio for MS, currently valued at 2.21, compared to the broader market-4.00-2.000.002.004.002.21-0.66
The chart of Omega ratio for MS, currently valued at 1.31, compared to the broader market0.501.001.502.001.310.92
The chart of Calmar ratio for MS, currently valued at 2.30, compared to the broader market0.002.004.006.002.30-0.45
The chart of Martin ratio for MS, currently valued at 9.14, compared to the broader market0.0010.0020.009.14-1.18
MS
JNJ

The current MS Sharpe Ratio is 1.54, which is higher than the JNJ Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of MS and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
1.54
-0.51
MS
JNJ

Dividends

MS vs. JNJ - Dividend Comparison

MS's dividend yield for the trailing twelve months is around 2.86%, less than JNJ's 3.40% yield.


TTM20242023202220212020201920182017201620152014
MS
Morgan Stanley
2.86%2.82%3.49%3.47%2.14%2.04%2.54%2.77%1.72%1.66%1.73%0.90%
JNJ
Johnson & Johnson
3.40%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

MS vs. JNJ - Drawdown Comparison

The maximum MS drawdown since its inception was -88.12%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for MS and JNJ. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.15%
-15.81%
MS
JNJ

Volatility

MS vs. JNJ - Volatility Comparison

Morgan Stanley (MS) has a higher volatility of 8.33% compared to Johnson & Johnson (JNJ) at 5.47%. This indicates that MS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
8.33%
5.47%
MS
JNJ

Financials

MS vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Morgan Stanley and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab